Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

L. Bartmann, D. Schumacher, S. von Stillfried, M. Sternkopf, S. Alampour-Rajabi, M.A.M.J. van Zandvoort, F. Kiessling*, Z.J. Wu*

*Corresponding author for this work

Research output: Contribution to journalErratum / corrigendum / retractionsAcademic

Original languageEnglish
Article number617329
Number of pages1
JournalFrontiers in Pharmacology
Publication statusPublished - 26 Nov 2020


  • cancer therapy
  • nanocarrier
  • rfvt
  • riboflavin
  • targeting molecules
  • theranostic
  • RFVT

Cite this